title: Management of a patient with schizophrenia and underlying pituitary macroadenoma.
authors.forename: Kah Wee
authors.initials: KW
authors.lastname: Ng
authors.forename: Jimmy
authors.initials: J
authors.lastname: Lee
authors.forename: Verma
authors.initials: V
authors.lastname: Swapna
mesh_terms: D000236:Adenoma / Q000150:complications* / Q000473:pathology; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000068180:Aripiprazole; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D001971:Bromocriptine / Q000009:adverse effects / Q000627:therapeutic use; D018492:Dopamine Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006727:Hormone Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications* / Q000209:etiology; D000077152:Olanzapine; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000150:complications* / Q000473:pathology; D015363:Quinolones / Q000009:adverse effects / Q000627:therapeutic use; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D014268:Trifluoperazine / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D006727:Hormone Antagonists; D010879:Piperazines; D015363:Quinolones; D012702:Serotonin Antagonists; D001569:Benzodiazepines; D014268:Trifluoperazine; D001971:Bromocriptine; D000068180:Aripiprazole; D018967:Risperidone; D000077152:Olanzapine